{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:34:02Z","timestamp":1772148842851,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3379,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>The Model for End-Stage Liver Disease (MELD) scoring system, a validated objective liver disease severity scale, was adopted in February 2002 to allocate cadaveric organs for liver transplantation (LT). To improve transplantability before succumbing to advanced disease, patients with low-stage hepatocellular carcinoma (HCC) are given extra points in this system commensurate with their predicted mortality. Our aims were to determine 1) any change in the pathological findings at LT following the implementation of this system and 2) the impact of scoring advantage given to early-stage HCC. Clinicopathologic findings were compared before (pre-MELD, n = 87) and after (MELD, n = 58) the introduction of the MELD system. The findings in the pre-MELD vs. MELD groups were as follows: HCC, 27.5% vs. 48.3% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001); portal vein thrombosis (PVT), 13.7% vs. 25.9% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.08); cholestasis, 16.1% vs. 32.7% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.026); inflammation grade of 2 or more, 43.7% vs. 48.3% (<jats:italic toggle=\"yes\">P<\/jats:italic> = not significant); hepatitis C (HCV), 45.9% vs. 51.7% (<jats:italic toggle=\"yes\">P<\/jats:italic> = not significant); HCV with lymphoid aggregates, 25% vs. 60% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003); HCV with hyperplastic hilar nodes, 15.0% vs. 36.6% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001); and post-LT HCC recurrence, 4.1% vs. 3.4% (<jats:italic toggle=\"yes\">P<\/jats:italic> = not significant). Non-HCC-related findings were further compared in the 2 subgroups of pre-MELD (n = 57) and MELD (n = 31) after exclusion of HCC and fulminant hepatic failure (FHF) cases, and only cholestasis was significantly increased in the subgroup MELD. In conclusion, increased incidence of native liver cholestasis in the MELD era may be the histologic correlate of clinically severe liver disease. The scoring advantage given to low-stage HCC did result in a significantly increased incidence of HCC in the MELD group, but it did not adversely affect the post-LT recurrence rate. <jats:bold>\n                                    Liver Transpl 12:958\u2013965, 2006.\n                                 <\/jats:bold>\n                                 <jats:bold>\u00a9 2006 AASLD.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20728","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T13:17:50Z","timestamp":1144329470000},"page":"958-965","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation"],"prefix":"10.1097","volume":"12","author":[{"given":"Urmila","family":"Khettry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gissou","family":"Azabdaftari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Pomfret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Pomposelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger L.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredric D.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20250124","first-page":"7","article-title":"RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, UNOSOPTN Liver and Intestine Transplantation Committee. Results of the first year of the new liver allocation plan.","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"key":"R2-12-20250124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"United Network for Organ Sharing Liver Disease Severity Score Committee. Model for endstage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"R3-12-20250124","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jlts.2002.35927","article-title":"UNOSOPTN Liver Disease Severity Score, UNOSOPTN Liver and Intestine, and UNOSOPTN Pediatric Transplantation Committees. The new liver allocation system: moving towards evidence based transplantation policy.","volume":"8","author":"Freeman JrRB, Wiesner","year":"2002","journal-title":"Liver Transpl"},{"key":"R4-12-20250124","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/jlts.2002.31340","article-title":"Model for endstage liver disease and ChildTurcottePugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients.","volume":"8","author":"Brown JrRS, Kumar","year":"2002","journal-title":"Liver Transpl"},{"key":"R5-12-20250124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1155\/2001\/743019","article-title":"Liver transplantation: evolving patient selection criteria.","volume":"15","author":"Yu","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"R6-12-20250124","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with endstage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R7-12-20250124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jlts.2003.50009","article-title":"Longitudinal assessment of mortality risk among candidates for liver transplantation.","volume":"9","author":"Merion","year":"2003","journal-title":"Liver Transpl"},{"key":"R8-12-20250124","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/gut.52.1.134","article-title":"MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.","volume":"52","author":"Botta","year":"2003","journal-title":"Gut"},{"key":"R9-12-20250124","first-page":"24","article-title":"Application of a continuous disease severity score to the OPTN liver waiting list.","volume":"19-","author":"Edwards","year":"2001","journal-title":"Clin Transpl"},{"key":"R10-12-20250124","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/jlts.2002.31749","article-title":"Predicting the probability of progressionfree survival in patients with small hepatocellular carcinoma.","volume":"8","author":"Cheng","year":"2002","journal-title":"Liver Transpl"},{"key":"R11-12-20250124","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/jlts.2002.34637","article-title":"Is MELD really the definitive score for liver allocation?","volume":"8","author":"Llado","year":"2002","journal-title":"Liver Transpl"},{"key":"R12-12-20250124","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/lt.20027","article-title":"Liver allocation for HCC: a moving target.","volume":"10","author":"Freeman","year":"2004","journal-title":"Liver Transpl"},{"key":"R13-12-20250124","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting.","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R14-12-20250124","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lt.20012","article-title":"Liver transplantation for hepatocellular carcinoma: the MELD impact.","volume":"10","author":"Sharma","year":"2004","journal-title":"Liver Transpl"},{"key":"R15-12-20250124","first-page":"167","article-title":"New scoring systems for severity outcomes of liver cirrhosis and hepatocellular carcinoma: current issues concerning the ChildTurcottePugh score and the Model of endstage liver disease (MELD) score.","volume":"9","author":"Lee","year":"2003","journal-title":"Taehan Kan Hakhoe Chi"},{"key":"R16-12-20250124","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jlts.2003.50090","article-title":"MELD score predicts 1year patient survival postorthotopic liver transplantation.","volume":"9","author":"Saab","year":"2003","journal-title":"Liver Transpl"},{"key":"R17-12-20250124","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jlts.2003.50122","article-title":"Model for endstage liver disease score does not predict patient or graft survival in living donor liver transplant recipients.","volume":"9","author":"Hayashi","year":"2003","journal-title":"Liver Transpl"},{"key":"R18-12-20250124","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1034\/j.1600-6143.2003.00092.x","article-title":"Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C.","volume":"3","author":"Onaca","year":"2003","journal-title":"Am J Transplant"},{"key":"R19-12-20250124","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF01536804","article-title":"VA Cooperative Study Group 119. Prognostic significance of cholestatic alcoholic hepatitis.","volume":"35","author":"Nissenbaum","year":"1990","journal-title":"Dig Dis Sci"},{"key":"R20-12-20250124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2559.1993.tb01179.x","article-title":"Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis.","volume":"23","author":"Harrison","year":"1993","journal-title":"Histopathology"},{"key":"R21-12-20250124","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.20709","article-title":"An inhibitor of cyclindependent kinase, stressinduced p21Waf1Cip1, mediates hepatocyte mitoinhibition during the evolution of cirrhosis.","volume":"41","author":"Lunz","year":"2005","journal-title":"Hepatology"},{"key":"R22-12-20250124","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.20020","article-title":"Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD.","volume":"10","author":"Hayashi","year":"2004","journal-title":"Liver Transpl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20728","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200606000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:08:14Z","timestamp":1737734894000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200606000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20728","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}